Stock Scorecard
Stock Summary for GSK Plc (GSK) - $33.60 as of 11/20/2024 4:08:51 PM EST
Total Score
9 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GSK
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GSK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GSK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GSK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GSK (54 out of 90)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 7 |
Latest News for for GSK
Financial Details for GSK
Company Overview |
|
|---|---|
| Ticker | GSK |
| Company Name | GSK Plc |
| Country | USA |
| Description | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/5/2025 |
Stock Price History |
|
| Last Day Price | 33.60 |
| Price 4 Years Ago | 38.47 |
| Last Day Price Updated | 11/20/2024 4:08:51 PM EST |
| Last Day Volume | 7,491,591 |
| Average Daily Volume | 7,411,620 |
| 52-Week High | 44.85 |
| 52-Week Low | 32.83 |
| Last Price to 52 Week Low | 2.35% |
Valuation Measures |
|
| Trailing PE | 21.73 |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 10.47 |
| Free Cash Flow Ratio | 21.54 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 0.81 |
| Total Cash Per Share | 1.56 |
| Book Value Per Share Most Recent Quarter | 3.43 |
| Price to Book Ratio | 3.84 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 2.18 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 2,040,250,000 |
| Market Capitalization | 68,552,400,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/15/2024 |
| Last Dividend Amount | 0.39 |
| Current Dividend Amount | 0.39 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 1.56 |
| Trailing Annual Dividend Yield | 4.69% |
| Forward Annual Dividend Rate | 1.35 |
| Forward Annual Dividend Yield | 4.04% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 5.02% |
| 5-Year Average Dividend Yield | 5.36% |
| 1-Year Dividend Growth Rate Percentage | -26.00% |
| 3-Year Dividend Growth Rate Percentage | -28.54% |
| 5-Year Dividend Growth Rate Percentage | -13.83% |
| All-Time Dividend Growth Rate Percentage | 9.85% |
| Dividend Payout Ratio | 101.55% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -28.20% |
| Annual Earnings Growth | -67.05% |
| Reported EPS 12 Trailing Months | 1.54 |
| Reported EPS Past Year | 3.48 |
| Reported EPS Prior Year | 3.87 |
| Net Income Twelve Trailing Months | 2,103,000,000 |
| Net Income Past Year | 4,928,000,000 |
| Net Income Prior Year | 14,956,000,000 |
| Quarterly Revenue Growth YOY | -1.70% |
| 5-Year Revenue Growth | -0.32% |
| Operating Margin Twelve Trailing Months | 0.08 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,192,000,000 |
| Total Cash Past Year | 2,936,000,000 |
| Total Cash Prior Year | 3,723,000,000 |
| Net Cash Position Most Recent Quarter | -10,962,000,000 |
| Net Cash Position Past Year | -11,218,000,000 |
| Long Term Debt Past Year | 14,154,000,000 |
| Long Term Debt Prior Year | 17,035,000,000 |
| Total Debt Most Recent Quarter | 14,154,000,000 |
| Equity to Debt Ratio Past Year | 0.49 |
| Equity to Debt Ratio Most Recent Quarter | 0.50 |
| Total Stockholder Equity Past Year | 13,347,000,000 |
| Total Stockholder Equity Prior Year | 10,598,000,000 |
| Total Stockholder Equity Most Recent Quarter | 14,008,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 3,440,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.69 |
| Free Cash Flow Past Year | 4,424,000,000 |
| Free Cash Flow Prior Year | 5,145,000,000 |
Options |
|
| Put/Call Ratio | 0.38 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.24 |
| MACD Signal | -1.05 |
| 20-Day Bollinger Lower Band | 33.50 |
| 20-Day Bollinger Middle Band | 38.94 |
| 20-Day Bollinger Upper Band | 44.39 |
| Beta | 0.33 |
| RSI | 27.62 |
| 50-Day SMA | 39.52 |
| 150-Day SMA | 37.99 |
| 200-Day SMA | 39.10 |
System |
|
| Modified | 11/21/2024 2:25:00 AM EST |